Combination of multiple alignment analysis and surface mapping paves a way for a detailed pathway reconstruction—The case of VHL (von Hippel‐Lindau) protein and angiogenesis regulatory pathway
暂无分享,去创建一个
[1] G. Semenza,et al. Regulation of mammalian O2 homeostasis by hypoxia-inducible factor 1. , 1999, Annual review of cell and developmental biology.
[2] J. Widom,et al. Structure of human methionine aminopeptidase-2 complexed with fumagillin. , 1998, Science.
[3] D. Eisenberg,et al. Detecting protein function and protein-protein interactions from genome sequences. , 1999, Science.
[4] W. Kaelin,et al. Structure of the VHL-ElonginC-ElonginB complex: implications for VHL tumor suppressor function. , 1999, Science.
[5] M. Ivan,et al. The von Hippel-Lindau tumor suppressor protein. , 2001, Current opinion in genetics & development.
[6] Christophe Béroud,et al. Software and database for the analysis of mutations in the VHL gene , 1998, Nucleic Acids Res..
[7] O. Lichtarge. Evolutionarily conserved Gaypy binding surfaces support amodel oftheG protein-receptor complex , 1996 .
[8] W. Kaelin,et al. The VHL tumour-suppressor gene paradigm. , 1998, Trends in genetics : TIG.
[9] K. Davies,et al. Lon protease preferentially degrades oxidized mitochondrial aconitase by an ATP-stimulated mechanism , 2002, Nature Cell Biology.
[10] S. Elledge,et al. Rbx1, a component of the VHL tumor suppressor complex and SCF ubiquitin ligase. , 1999, Science.
[11] Paramvir S. Dehal,et al. Whole-Genome Shotgun Assembly and Analysis of the Genome of Fugu rubripes , 2002, Science.
[12] D. Church,et al. Cross-species sequence comparisons: a review of methods and available resources. , 2003, Genome research.
[13] R. Klausner,et al. Identification of the von Hippel-lindau tumor-suppressor protein as part of an active E3 ubiquitin ligase complex. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[14] P. Ratcliffe,et al. The pVHL-hIF-1 system. A key mediator of oxygen homeostasis. , 2001, Advances in experimental medicine and biology.
[15] D. Morrison. Phylogenetic tree-building. , 1996, International journal for parasitology.
[16] W. Kaelin,et al. Regulation of Hypoxia-Inducible mRNAs by the von Hippel-Lindau Tumor Suppressor Protein Requires Binding to Complexes Containing Elongins B/C and Cul2 , 1998, Molecular and Cellular Biology.
[17] A. Kibel,et al. Binding of the von Hippel-Lindau tumor suppressor protein to Elongin B and C , 1995, Science.
[18] W. S. Valdar,et al. Scoring residue conservation , 2002, Proteins.
[19] C. Wykoff,et al. The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis , 1999, Nature.
[20] G. Semenza,et al. FIH-1: a novel protein that interacts with HIF-1alpha and VHL to mediate repression of HIF-1 transcriptional activity. , 2001 .
[21] William Arbuthnot Sir Lane,et al. Elongin (SIII): a multisubunit regulator of elongation by RNA polymerase II , 1995, Science.
[22] M. Nei,et al. Phylogenetic analysis in molecular evolutionary genetics. , 1996, Annual review of genetics.
[23] M. Ivan,et al. Structure of an HIF-1α-pVHL Complex: Hydroxyproline Recognition in Signaling , 2002, Science.
[24] Fugu: a compact vertebrate reference genome , 2000, FEBS letters.
[25] F. Cohen,et al. An evolutionary trace method defines binding surfaces common to protein families. , 1996, Journal of molecular biology.
[26] A. Varshavsky,et al. The N-end rule: functions, mysteries, uses. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[27] F E Cohen,et al. Identification of functional surfaces of the zinc binding domains of intracellular receptors. , 1997, Journal of molecular biology.